SCHEMBL7300567

SCHEMBL7300567

C1=C2SCNC2CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14919192 0.60
SCHEMBL2456115 0.56
SCHEMBL17310757 0.56 HTR3A (0.37)
SCHEMBL3576495 0.55
Hydrochloric Acid SCHEMBL17396356 0.55 HTR3A (0.36)
SCHEMBL4480663 0.53
SCHEMBL477075 0.51
SCHEMBL20521142 0.49
SCHEMBL566951 0.46
SCHEMBL2042790 0.46

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992021349-A1 COMBINATIONS OF ALPHA-2 ADRENERGIC AGONISTS WITH ALPHA-3 ANTAGONISTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. (US) 1992-12-10 WO disclosed
EP-0347766-A2 4,5,7,8-Tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as medicaments Dr. Karl Thomae GmbH (DE) 1989-12-27 EP disclosed